StonvexLoading…
StonvexStonvexStonvexCore line items from IR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $7.65B | $7.24B | $6.88B | $5.92B |
Operating Income | $1.14B | $1.30B | $1.16B | $817.30M |
Net Income | $581.40M | $838.60M | $778.70M | $604.70M |
EPS (Diluted) | $1.45 | $2.06 | $1.90 | $1.47 |
Total Assets | $18.30B | $18.01B | $15.56B | $14.77B |
Total Liabilities | $8.14B | $7.76B | $5.72B | $5.51B |
Cash & Equivalents | $1.25B | $1.54B | $1.60B | $1.61B |
Free Cash Flow OCF − CapEx | $1.22B | $1.25B | $1.27B | $770.80M |
Shares Outstanding | 391.12M | 402.88M | 403.35M | 405.12M |